Tavia Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in Almaty, Almatinskaya Oblast. The company went IPO on 2024-12-04. The Company’s investment thesis prioritizes target businesses primarily in North America and Europe, with an interest in new energy businesses, circular economy initiatives, and agricultural and food technologies. The firm is neither engaged in any operations nor generated any revenues.
Tavia Acquisition Corp 最大收入來源為 Human Mesenchymal and Other Stem Cell and Cell-derived Products,在最近的收益報告中收入為 48,900。就地區而言,China 是 Tavia Acquisition Corp 的主要市場,收入為 48,900。